Company
Prothena
Pioneering Neuroscience
Also known as Prothena Corporation plc
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Legal name
- Prothena Corporation plc
- prothena.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Prothena is a clinical-stage biotechnology company with expertise in protein dysregulation and a diverse pipeline of novel investigational therapies for neurodegenerative and rare peripheral amyloid diseases.
Funding snapshot
- Total raised
- $50MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $50M2018-03-21
Funding rounds
- Round, 2018
- $50M2018-03-21, SEC form D sold, 1 investor
Loading relationship preview